In cooperation with


Ovarian cancer

Ovarian cancer is one of the most frequent gynecological malignancies in the western world.

Based on the lacking screening and early detection tools and the long symptom-free interval most of the patients will be diagnosed in an advanced tumor stage. Surgery with the primary objective of maximal cytoreduction is the most relevant prognostic factor. Subsequent chemotherapy with placlitaxel and carboplatin is the current standard of care. CA-125 based therapy is not indicated due the fact that an »earlier« diagnosis can not improve the progression-free survival and overall survival.

CME Prakt Fortbild Gynakol Geburtsmed Gynakol Endokrinol 2011; 7(1): 84-95

Ovarian cancer, surgery, chemotherapy, review, cancer care

Jalid Sehouli
Klinik für Gynäkologie, Charité Campus Virchow-Klinikum, Berlin
Reviewer: Oumar Camara, Jena
und Werner Lichtenegger, Berlin

Sehouli J. Ovarialkarzinom ... Gynakol Geburtsmed Gynakol Endokrinol 2011; 7(1): 84-95 publiziert 31.03.11 ©akademos Wissenschaftsverlag 2011 ISSN 1614-8533